StemCell Institute Inc. (7096.T)
JPY 1332.0
(0.23%)
JPY 1332.0
(0.23%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.54 Billion JPY | 12.59% |
| 2022 | 5.81 Billion JPY | 11.43% |
| 2021 | 5.21 Billion JPY | 31.76% |
| 2020 | 3.95 Billion JPY | 11.07% |
| 2019 | 3.56 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 6.7 Billion JPY | 2.46% |
| 2023 Q4 | 6.54 Billion JPY | 3.92% |
| 2023 Q3 | 6.29 Billion JPY | 2.48% |
| 2023 Q2 | 6.14 Billion JPY | 4.07% |
| 2023 Q1 | 5.9 Billion JPY | 1.59% |
| 2023 FY | 6.54 Billion JPY | 12.59% |
| 2022 Q3 | 5.58 Billion JPY | 2.64% |
| 2022 Q2 | 5.44 Billion JPY | 0.0% |
| 2022 Q4 | 5.81 Billion JPY | 3.98% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 6.58 Billion JPY | 0.702% |
| PRISM BioLab Co.,LTD | 1.21 Billion JPY | -440.113% |
| GNI Group Ltd. | 62.39 Billion JPY | 89.513% |
| Linical Co., Ltd. | 18.53 Billion JPY | 64.708% |
| Trans Genic Inc. | 9.81 Billion JPY | 33.309% |
| MEDINET Co., Ltd. | 5.63 Billion JPY | -16.133% |
| Soiken Holdings Inc. | 6.94 Billion JPY | 5.803% |
| Cytori Cell Research Institute, Inc. | 5.81 Billion JPY | -12.495% |
| AnGes, Inc. | 28.89 Billion JPY | 77.354% |
| OncoTherapy Science, Inc. | 867.27 Million JPY | -654.441% |
| Nxera Pharma Co., Ltd. | 157.19 Billion JPY | 95.838% |
| Immuno-Biological Laboratories Co., Ltd. | 1.61 Billion JPY | -304.247% |
| NanoCarrier Co., Ltd. | 5.07 Billion JPY | -29.022% |
| Carna Biosciences, Inc. | 4.34 Billion JPY | -50.419% |
| CanBas Co., Ltd. | 2.43 Billion JPY | -168.946% |
| D. Western Therapeutics Institute, Inc. | 2.37 Billion JPY | -175.687% |
| RaQualia Pharma Inc. | 6.93 Billion JPY | 5.587% |
| Chiome Bioscience Inc. | 1.75 Billion JPY | -273.58% |
| Kidswell Bio Corporation | 5.08 Billion JPY | -28.66% |
| PeptiDream Inc. | 67.12 Billion JPY | 90.253% |
| Oncolys BioPharma Inc. | 2.04 Billion JPY | -220.645% |
| Ribomic Inc. | 3.54 Billion JPY | -84.454% |
| SanBio Company Limited | 5.04 Billion JPY | -29.635% |
| Healios K.K. | 15.15 Billion JPY | 56.826% |
| BrightPath Biotherapeutics Co., Ltd. | 1.23 Billion JPY | -431.846% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 3.01 Billion JPY | -116.945% |
| Delta-Fly Pharma, Inc. | 1.47 Billion JPY | -343.853% |
| StemRIM | 9.08 Billion JPY | 27.94% |
| CellSource Co., Ltd. | 6.87 Billion JPY | 4.894% |
| FunPep Company Limited | 2.49 Billion JPY | -162.654% |
| Kringle Pharma, Inc. | 2.61 Billion JPY | -149.864% |
| Stella Pharma Corporation | 3.82 Billion JPY | -71.257% |
| TMS Co., Ltd. | 3.55 Billion JPY | -84.065% |
| Noile-Immune Biotech Inc. | 5.77 Billion JPY | -13.223% |
| Cuorips Inc. | 6.18 Billion JPY | -5.794% |
| K Pharma,Inc. | 3.31 Billion JPY | -97.443% |
| Takara Bio Inc. | 123.2 Billion JPY | 94.689% |
| ReproCELL Incorporated | 9.05 Billion JPY | 27.722% |
| PhoenixBio Co., Ltd. | 2.71 Billion JPY | -140.969% |
| Japan Tissue Engineering Co., Ltd. | 6.98 Billion JPY | 6.377% |
| CellSeed Inc. | 2.46 Billion JPY | -165.356% |